$HHSE-NEWS:..With.the.movie.TORN, Hemdale-is

New Post Public Reply Private Reply Replies (0) Message Board
HHSErocks jmtimz #80
119
$HHSE-NEWS:..With.the.movie.TORN, Hemdale-is Back.

https://deadline.com/2025/07/hemdale-back-tor...236456985/

Mike Fleming Jr: Hemdale Back From Dead With Provocative ‘Torn’;

By Mike Fleming Jr

Mike Fleming Jr
Co-Editor-in-Chief, Film

@DeadlineMike
More Stories By Mike
Mike Fleming Jr: Hemdale Back From Dead With Provocative ‘Torn’; Donald Trump’s Beak-Wetting Right Out Of ‘The Godfather Part II’
Richard Gladstein Tapped Executive Director Of Hamptons Film Festival
Langley Perer Loses Cancer Battle; Manager And Producer Was 44
View All

July 14, 2025 1:13pm
2
Comments
Services to share this page.
Share on Facebook
Post
Share to Flipboard
Email
Show more sharing options
Donald Trump and Gastone Moschin as Don Fanucci in a scene from the movie The Godfather Part II
Donald Trump and Gastone Moschin as Don Fanucci in 'The Godfather Part II'
Getty/Paramount

EXCLUSIVE: Hemdale Films, the one film production company to generate back-to-back Best Picture Oscar winners (Platoon and The Last Emperor) , is re-emerging for the first time in forever . Revived by Eric Parkinson as a releasing label, Hemdale will release Torn: The Israeli-Palestine Poster War on NYC Streets .

The provocative documentary by director Nim Shapira focuses on the street war that broke out between pro-Israel and pro-Palestinian groups that tore down each other’s messages about the 250 hostages taken by Hamas during the October 7 terror attack in Israel. The posters inflamed heated passion among those who put them up to raise awareness of the hostages and those who tore them down to show their opposition to Israel’s subsequent Gaza offensive. It led to heated arguments and often violence.

Hemdale will open the film in theaters September 5 in New York and Los Angeles with a rollout to follow in the fall and a digital release later on.

Related Stories
Donald Trump and the logo for CBS' 60 Minutes
What’s Next In The Trump-CBS, Paramount-Skydance Saga

Trump Celebrity Supporters: Famous Folks In Favor Of The 47th President
Shapira focused on 10 deeply personal stories for a film that unravels the ideological conflict and explores the limits of empathy in today’s fractured public discourse. Pic has so far had over 50 pre-release screenings across the U.S. and Canada, igniting discourse in major cities including New York, Boston, Chicago, Toronto and San Francisco.

Watch on Deadline
01:45

33:57





So how did Hemdale, the once highflying independent company started by John Daly and actor David Hemmings — best known for playing a Roman senator in Ridley Scott’s Gladiator — emerge from film history to be back in the game 30 years after becoming defunct?

First brought in to the label at the behest of owner Credit Lyonnais in 1991, Parkinson kept a candle in the window all these years for Hemdale, after the company became functionally idle following the sale of its Oscar-winning film library to MGM in 1996. Parkinson said he walked away with the Hemdale name rights, then waited for the right film to relaunch the brand as a releasing division under Hannover House, the 32-year-old independent media company .

Hemdale was started by Daly, who sold insurance, and Hemmings way back in 1967. They first managed rock bands like Black Sabbath, which coincidentally just played its final concert for the Ozzy Osbourne-fronted metal band. Hemdale financed live productions like Grease, and promoted boxing matches like the Muhammad Ali-George Foreman clash “Rumble in the Jungle.” But the true passion for Daly and Hemmings was film, and they had an enviable run.

For a while. The hits ranged from The Terminator to Hoosiers, Salvador, River’s Edge, At Close Range, Platoon, The Last Emperor and Return of the Living Dead. As is often the case with taste-making indies, money was always a problem.

I recall James Cameron once telling me that he had to find the money to end his seminal film with Linda Hamilton’s Sarah Connor and her “You’re terminated, f*cker” factory scene. Daly told Cameron he didn’t have the money for that, and to end the picture earlier, when Michael Biehn’s Kyle Reese places the explosive in the gasoline tanker driven by the cyborg played by Arnold Schwarzenegger. You wonder if that franchise would have become all that it did, had they cheap-ed out on the ending. Cameron, who earlier sold his rights to producer Gale Anne Hurd for $1 with the caveat he could not be replaced as director, would not be denied.

That predated Parkinson, who arrived on the scene in 1991 as a crisis manager planted by the French bank Credit Lyonnais to protect its investment in Hemdale and other Hollywood holdings.

“My title was President of the ‘to be formed Home Video Division,’” he recalled. “And the video division did great. We generated a lot of money. We were able to pay down the debt from $110 million to $58 million, and I attribute a lot of that to Terminator and tying in the re-release of Terminator with Terminator 2. After a period of time, Credit Lyonnais lost interest in the movie business because of the amount of money it invested, mostly in Giancarlo Parretti, and MGM. They took a lot of the companies, Orion, Dino De Laurentiis, Embassy Pictures, Hemdale, Cannon Pictures, all those companies that had loans. They rolled them all into MGM to try to make that business work. After five years there was a forced unwinding of Hemdale, and that hit John and David harder than anybody else. It had been their whole lives. I was still a young guy in my late 30s, and I made the deal that at some point in time, if I had meritorious pictures, then I would relaunch the label. The brand name was the only thing that wasn’t sold with the assets.”

He reincorporated Hemdale, and waited for the right acquisition to come along. He sparked to Torn.

“It had to be something I felt would honor the memory of John’s commitment to quality. And that’s not to say that Hannover House releases don’t have quality, but let’s be honest, some low-budget horror films aren’t going to be quite as commercially or critically meritorious as something that potentially has an Oscar nomination.”

Parkinson hopes Hemdale can become active again, not just as a distributor but as a maker of movies. They are percolating Tempus Porta, a film gearing up to shoot in Malta, and they’re attempting to work with Oliver Stone again on A Child’s Night Dream. That’s a novel Stone wrote before he served as an infantryman in Vietnam, getting wounded twice in combat and winning the Bronze Star, Purple Heart and other medals, experiences that informed his Best Picture- and Best Director-winning film Platoon. Stone’s son Sean has been pining to direct it.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 8

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 12

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 19

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 19

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 17

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 9

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 11

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading

Top 5 Most Recently Viewed Articles

ASP Isotopes Inc. Investors Urged to Join Class Action Lawsuit

Updated Category News Views 135

Class Action Lawsuit Announced for ASP Isotopes Investors ASP Isotopes Inc. has recently found itself in the midst of a class action lawsuit that many investors might want to pay attention to. This lawsuit has been initiated by Bronstein, Gewirtz & Grossman, LLC, a well-regarded law firm specializing in securities fraud. Investors whose financial interests have suffered...

Continue Reading
Boeing and Korean Air Announce Historic $36 Billion Purchase

Updated Category News Views 136

Boeing Secures Major Deal with Korean Air Boeing Co. (NASDAQ: BA) has entered into a remarkable $36.2 billion agreement with Korean Air. This historic deal encompasses the purchase of 103 aircraft, a strategic move coinciding with efforts to bolster American business interests internationally. Details of the Agreement and Fleet Modernization Announced recently, this...

Continue Reading
Debbie's Dream Foundation Launches 2026 Youth Art Contest

Updated Category News Views 20

Young Artists Called to Inspire a Cancer-Free World What's the first image that pops into your head when you think of a world free from cancer? That's the magic question on deck for this year's Youth Art Contest by Debbie's Dream Foundation. Imaginations are set to run wild as the competition opens its gates to artists under 18, calling for visions splashed across...

Continue Reading
European Stocks Surge Amid Easing Middle East Tensions

Updated Category News Views 67

European Markets Rally on Positive Sentiment European stock markets experienced a modest rise recently, primarily driven by the easing geopolitical tensions in the Middle East. This optimism comes at a crucial time as investors prepare for a week filled with potential market influences. As of early trading, Germany's DAX index climbed by 0.3%, while France's CAC 40 saw an...

Continue Reading
XPeng's Middle East Plans and the EV Landscape Ahead

Updated Category News Views 185

A Week of Mixed Developments in the EV and Travel Sectors This week marked a significant moment in the tech and travel sectors, showcasing both opportunities and challenges. Chinese electric vehicle (EV) manufacturer XPeng Inc. has announced its ambitious expansion plans aimed at the Middle East and Africa. This strategic move aligns with China's broader goals of...

Continue Reading